ERBB2 and cancer: Interestingly, in the HER2-positive subtype, VISTA-positive cancer cells were associated with the tumor metastization process (p = 0.0200), suggesting that cancer cells release VISTA in order to downregulate the tumor immune response [44,51,52,53] and to evade the primary tumor location.